Goldman Sachs Group Inc. cut its stake in shares of HealthSouth Corporation (NYSE:HLS) by 67.9% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 343,876 shares of the company’s stock after selling 728,256 shares during the period. Goldman Sachs Group Inc. owned approximately 0.35% of HealthSouth Corporation worth $16,644,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. First Mercantile Trust Co. increased its position in shares of HealthSouth Corporation by 18.8% during the second quarter. First Mercantile Trust Co. now owns 2,720 shares of the company’s stock valued at $132,000 after acquiring an additional 430 shares during the last quarter. Acrospire Investment Management LLC increased its position in shares of HealthSouth Corporation by 64.7% during the second quarter. Acrospire Investment Management LLC now owns 2,800 shares of the company’s stock valued at $136,000 after acquiring an additional 1,100 shares during the last quarter. Advisor Group Inc. increased its position in shares of HealthSouth Corporation by 33.8% during the second quarter. Advisor Group Inc. now owns 3,092 shares of the company’s stock valued at $149,000 after acquiring an additional 781 shares during the last quarter. Petrus Trust Company LTA acquired a new stake in shares of HealthSouth Corporation during the second quarter valued at about $210,000. Finally, HL Financial Services LLC acquired a new stake in shares of HealthSouth Corporation during the second quarter valued at about $213,000. Institutional investors and hedge funds own 93.08% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “HealthSouth Corporation (HLS) Holdings Decreased by Goldman Sachs Group Inc.” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another website, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The legal version of this article can be accessed at https://www.thecerbatgem.com/2017/10/16/healthsouth-corporation-hls-holdings-decreased-by-goldman-sachs-group-inc.html.

In other news, CEO Mark J. Tarr sold 22,625 shares of the stock in a transaction that occurred on Monday, August 7th. The stock was sold at an average price of $43.00, for a total transaction of $972,875.00. Following the completion of the transaction, the chief executive officer now directly owns 283,134 shares in the company, valued at approximately $12,174,762. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 1.60% of the stock is owned by company insiders.

HealthSouth Corporation (HLS) opened at 45.23 on Monday. The company has a 50 day moving average of $45.19 and a 200-day moving average of $45.39. The firm has a market cap of $4.47 billion, a PE ratio of 16.48 and a beta of 0.58. HealthSouth Corporation has a one year low of $36.97 and a one year high of $49.71.

HealthSouth Corporation (NYSE:HLS) last posted its earnings results on Monday, July 31st. The company reported $0.71 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.68 by $0.03. The firm had revenue of $981.30 million during the quarter, compared to the consensus estimate of $976.46 million. HealthSouth Corporation had a net margin of 6.70% and a return on equity of 25.07%. The company’s revenue was up 6.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.69 EPS. On average, equities research analysts predict that HealthSouth Corporation will post $2.71 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Monday, October 2nd will be given a $0.25 dividend. This is an increase from HealthSouth Corporation’s previous quarterly dividend of $0.24. The ex-dividend date of this dividend is Friday, September 29th. This represents a $1.00 annualized dividend and a yield of 2.21%. HealthSouth Corporation’s dividend payout ratio (DPR) is 36.76%.

A number of equities research analysts have weighed in on the stock. Zacks Investment Research cut shares of HealthSouth Corporation from a “buy” rating to a “hold” rating in a research report on Monday, July 3rd. Royal Bank Of Canada reiterated a “buy” rating and set a $53.00 price target on shares of HealthSouth Corporation in a research report on Wednesday, July 5th. Mizuho lifted their price target on shares of HealthSouth Corporation from $44.00 to $47.00 and gave the company a “neutral” rating in a research report on Monday, July 10th. ValuEngine upgraded shares of HealthSouth Corporation from a “hold” rating to a “buy” rating in a research report on Friday, July 7th. Finally, Robert W. Baird reiterated a “buy” rating and set a $55.00 price target on shares of HealthSouth Corporation in a research report on Monday, October 9th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and four have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $50.38.

HealthSouth Corporation Profile

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Institutional Ownership by Quarter for HealthSouth Corporation (NYSE:HLS)

Receive News & Stock Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related stocks with our FREE daily email newsletter.